Seizures Market Growth Opportunities: Insights from 2025–2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Anticipated Size Of The Seizures Market Over The Five-Year Period 2025–2029?

The seizures market has shown substantial expansion in recent years. It is anticipated to increase from $4.1 billion in 2024 to $4.34 billion in 2025, at a compound annual growth rate (CAGR) of 5.8%. The key factors contributing to its historical growth include the rising prevalence of epilepsy and seizure disorders, increasing awareness and diagnosis rates, growing research and development for neurological disorders, increasing government and non-profit initiatives for epilepsy awareness, and the rising geriatric population.

The seizures market is anticipated to show significant expansion in the coming years. By 2029, its valuation is projected to reach $5.45 billion, progressing at a compound annual growth rate (CAGR) of 5.9%. This expected growth during the forecast period is driven by an increasing geriatric population prone to neurological conditions, rising R&D investments in seizure therapeutics, a global increase in healthcare expenditure, a growing demand for epilepsy medications, and a rise in seizure disorder cases. Prominent trends throughout this period include advancements in seizure detection and monitoring devices, progress impacting drug approvals and reimbursements, breakthroughs in genetic research for precise seizure therapies, the adoption of digital health solutions for remote seizure monitoring, and ongoing developments in epilepsy drugs.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=23511&type=smp

Which Major Market Drivers Are Shaping The Future Of The Seizures Market?

A rising incidence of traumatic brain injuries is projected to fuel the expansion of the seizures market in the future. Traumatic brain injuries (TBI) are characterized as brain damage resulting from an abrupt external impact like a strike, jolt, or a penetrating head wound. The surge in traumatic brain injuries stems from an uptick in road accidents, with high-speed crashes and inattentive driving contributing to more severe head trauma. Seizures can act as an initial sign of traumatic brain injuries, assisting medical professionals in the more effective diagnosis and management of underlying brain harm. For example, a report from the South Dakota Department of Health (SDDOH), a government agency based in South Dakota, indicated in October 2023 that in 2022, South Dakota recorded the 9th highest age-adjusted TBI-related death rate, reaching 26.4 per 100,000. Additionally, data from the American Association of Neurological Surgeons, a US-based professional body, released in April 2024, estimates that annually between 1.7 and 3.8 million traumatic brain injuries occur in the US. Consequently, the rising occurrence of traumatic brain injuries is driving the growth of the seizures market.

What Are The Segment Types Shaping The Seizures Market?

The seizuresmarket covered in this report is segmented –

1) By Drug Type: First Generation Anti-Epileptics; Second Generation Anti-Epileptics; Third Generation Anti-Epileptics

2) By Route Of Administration: Oral; Parenteral; Topical

3) By Distribution Channel: Hospitals Pharmacies; Independent Pharmacies; Online Pharmacies

4) By End-User: Hospitals And Clinics; Ambulatory Surgical Centers; Homecare Settings; Other End-Users

Subsegments:

1) By First Generation Anti-Epileptics: Phenytoin; Carbamazepine; Valproate; Phenobarbital; Primidone; Ethosuximide

2) By Second Generation Anti-Epileptics: Lamotrigine; Levetiracetam; Topiramate; Oxcarbazepine; Zonisamide; Gabapentin; Pregabalin

3) By Third Generation Anti-Epileptics: Lacosamide; Perampanel; Brivaracetam; Eslicarbazepine; Cenobamate

What Are The Latest Industry Trends Transforming The Seizures Market?

Leading companies within the seizures market are developing innovative products, such as buccal film, to enhance both treatment accessibility and patient compliance. A buccal film is characterized as a thin, dissolvable strip that is administered by placing it against the inner lining of the cheek (buccal mucosa), enabling the drug to be absorbed directly into the bloodstream. For instance, in December 2024, Aquestive Therapeutics Inc., a US-based pharmaceutical company, secured U.S. FDA approval for orphan drug exclusivity for Libervant (diazepam) buccal film, specifically intended for pediatric patients aged two to five with seizure clusters. This innovative formulation provides a non-invasive, easy-to-administer alternative to traditional diazepam delivery methods, ensuring rapid absorption through the buccal mucosa for a faster onset of action. As the first and only orally administered diazepam film approved for this age group, Libervant aims to improve caregiver convenience and enhance patient compliance. This exclusivity further solidifies Aquestive’s position in advancing oral film-based epilepsy therapies.

Who Are The Prominent Global Companies Shaping The Seizures Market?

Major companies operating in the seizures market are Johnson & Johnson Service Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Novartis AG, GlaxoSmithKline plc, Viatris Inc., Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., UCB S.A., Eisai Co. Ltd., H. Lundbeck A/S, Zydus Lifesciences Limited, SK Biopharmaceuticals Co. Ltd., Neurocrine Biosciences Inc., Supernus Pharmaceuticals Inc., Taro Pharmaceutical Industries Ltd., Marinus Pharmaceuticals Inc., Eton Pharmaceuticals Inc., Sunovion Pharmaceuticals Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/seizures-global-market-report

Which Region Currently Holds The Largest Share Of The Seizures Market?

North America was the largest region in the seizures market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the seizures market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Seizures Market Report:

https://www.thebusinessresearchcompany.com/customise?id=23511&type=smp

Browse Through More Reports Similar to the Global Seizures Market 2025, By The Business Research Company

Grand Mal Seizure Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/grand-mal-seizure-treatment-global-market-report

Brain Tumor Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/brain-tumor-drugs-global-market-report

Brain And Neuroimaging Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/brain-and-neuroimaging-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795